SeeDevice Inc. Achieves Recognition for Sensor Technology Innovation
Dr. Hoon Kim, SeeDevice Inc. Founder and CEO (Photo Credit: SeeDevice Inc.)
ORANGE, Calif., December 21, 2023 (VSNewsNetwork.com) - SeeDevice Inc., a developer specializing in QMOS™ (Quantum effect CMOS) SWIR sensors, has recently garnered notable industry recognition, securing awards such as "20 Most Innovative Business Leaders to Watch 2023" by Global Business Leaders, "Top 10 Admired Leaders 2023" by Industry Era, and "Most Innovative Image Technology Company 2023" by Corporate Vision; according to a recent press release. These accolades reflect the company's impact on the sensor technology sector and its leadership in innovation.
Senior Vice President Sean Oh attributes the recognition to the leadership at SeeDevice, stating, “This acknowledgment is attributed to Dr. Kim's leadership and technical prowess at SeeDevice, motivating the entire team to surpass technological development and expectations in response to evolving business environments.”
According to the company, their technology aims to extend the capabilities of CMOS sensors into the SWIR range, utilizing plasmonic and quantum tunneling concepts to allow visibility beyond conventional light spectrums. This approach is designed to offer solutions that are both cost-effective and high-performing.
Dr. Hoon Kim, founder and CEO of SeeDevice, spoke about the company's commitment to advancing sensor technology, noting, "SeeDevice is revolutionizing the sensor industry by unlocking the untapped potential of SWIR technology. With our high sensitivity, nanosecond integration time, and wide spectral range, we are not only changing the landscape for industrial applications but also bringing affordable SWIR sensors to consumers. Having made breakthroughs with our non-invasive continuous glucose monitoring (NI-CGM) device, combining AI and machine learning technology with the expectation of achieving industry-leading accuracy will aid the world by providing an affordable solution for diabetics worldwide.”
The company reports that it has developed a prototype for a non-invasive continuous glucose monitoring device and is currently in the process of clinical trials, with plans to enter the CGM market in the near future.
To find out more about SeeDevice Inc. and its pioneering QMOS™ technology, visit www.seedevice.com.
Source: SeeDevice Inc. via Newswire
